Seven Oral Presentations: Innovent to Present Breakthrough Clinical Data of IBI363(PD-1/IL-2α-bias)and Other Novel Drug Candidates at the 2025 ASCO Annual Meeting

Seven Oral Presentations: Innovent to Present Breakthrough Clinical Data of IBI363(PD-1/IL-2α-bias)and Other Novel Drug Candidates at the 2025 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU,China, April 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

SimonMed Imaging Partners with Lunit to Deliver Best-in-Class AI for Breast Cancer Detection

SimonMed Imaging Partners with Lunit to Deliver Best-in-Class AI for Breast Cancer Detection

A Major Leap Forward in Patient Health and the Future of Mammography PHOENIX, April 24, 2025 /PRNewswire/ -- SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce...

Appotronics and Valeo announce strategic partnership for next-generation front lighting system

Appotronics and Valeo announce strategic partnership for next-generation front lighting system

Valeo and Appotronics will collaborate to create new front lighting systems that utilize innovative laser video projection technology. These innovative solutions will enhance adaptive lighting (ADB) functionalities in vehicles, significantly...

Tencent Cloud and Tabelog Partner to Provide Convenience to Travelers Visiting Japan from China

Tencent Cloud and Tabelog Partner to Provide Convenience to Travelers Visiting Japan from China

New Tabelog Weixin Mini Program promotes inbound tourism by boosting Chinese visitors' convenience and providing more opportunities for restaurants in Japan HONG KONG, April 23, 2025 /PRNewswire/ -- Tencent Cloud, the cloud business of global...

Aptos Powers EXPO2025 DIGITAL WALLET, Enhancing User Experience for Millions of Visitors

Aptos Powers EXPO2025 DIGITAL WALLET, Enhancing User Experience for Millions of Visitors

- The EXPO2025 DIGITAL WALLET is the digital wallet service for the Expo 2025 Osaka, Kansai, Japan with over 28 million visitors expected from April to October 2025. - As of April 21, the wallet has processed over 558,000 transactions and attracted...

S2C and Andes Technology Announce FPGA-Based Prototyping Partnership to Accelerate Advanced RISC-V SoC Development

S2C and Andes Technology Announce FPGA-Based Prototyping Partnership to Accelerate Advanced RISC-V SoC Development

SAN JOSE, Calif., April 23, 2025 /PRNewswire/ -- S2C, a global leader in FPGA-based prototyping solutions, and Andes Technology, a premier provider of high-performance, low-power RISC-V processor IP solutions, today announced the results of a...

Baidu to Report First Quarter 2025 Financial Results on May 21, 2025

Baidu to Report First Quarter 2025 Financial Results on May 21, 2025

BEIJING, April 22, 2025 /PRNewswire/ -- Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"), a leading AI company with strong Internet foundation, today announced that it will report its financial...

TOYO Co., Ltd to Announce Second Half and Fiscal Year 2024 Financial Results on April 28, 2025

TOYO Co., Ltd to Announce Second Half and Fiscal Year 2024 Financial Results on April 28, 2025

TOKYO, April 21, 2025 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO) (OTC: TOYWF), a solar solution company, today announced it will host a conference call to discuss second half and fiscal year 2024 results on Monday, April 28, 2025. Conference Call...

Akeso's Ebdarokimab ( IL - 12/IL - 23 Dual - Targeted Monoclonal Antibody) Approved in China for Moderate - to - Severe Plaque Psoriasis

Akeso's Ebdarokimab ( IL - 12/IL - 23 Dual - Targeted Monoclonal Antibody) Approved in China for Moderate - to - Severe Plaque Psoriasis

HONG KONG, April 18, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, has received marketing approval from the National...

Yunji to Report Fourth Quarter and Full Year 2024 Financial Results on April 21, 2025

Yunji to Report Fourth Quarter and Full Year 2024 Financial Results on April 21, 2025

HANGZHOU, China, April 17, 2025 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that it plans to release its fourth quarter and full year 2024 financial...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 41
  • menu
    menu